Literature DB >> 25200759

Bleeding complication with dual antiplatelet therapy: spontaneous uvula hematoma.

Nicholas G Kounis1, Periklis Davlouros2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25200759      PMCID： PMC4203606          DOI： 10.1503/cmaj.140270

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Uvula haematoma: a rare complication after thrombolysis and intensive anti-platelet treatment.

Authors:  Mehmet Kayrak; Mehmet S Ulgen; Mehmet Yazici; Duygu Kiliç; Hasan Gok
Journal:  Ann Card Anaesth       Date:  2007-07

2.  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

Authors:  Roxana Mehran; Usman Baber; Philippe Gabriel Steg; Cono Ariti; Giora Weisz; Bernhard Witzenbichler; Timothy D Henry; Annapoorna S Kini; Thomas Stuckey; David J Cohen; Peter B Berger; Ioannis Iakovou; George Dangas; Ron Waksman; David Antoniucci; Samantha Sartori; Mitchell W Krucoff; James B Hermiller; Fayaz Shawl; C Michael Gibson; Alaide Chieffo; Maria Alu; David J Moliterno; Antonio Colombo; Stuart Pocock
Journal:  Lancet       Date:  2013-09-01       Impact factor: 79.321

3.  Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

Authors:  Peter B Berger; Deepak L Bhatt; Valentin Fuster; P Gabriel Steg; Keith A A Fox; Mingyuan Shao; Danielle M Brennan; Werner Hacke; Gilles Montalescot; Steven R Steinhubl; Eric J Topol
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

4.  Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.

Authors:  Morten Lamberts; Jonas Bjerring Olesen; Martin Huth Ruwald; Carolina Malta Hansen; Deniz Karasoy; Søren Lund Kristensen; Lars Køber; Christian Torp-Pedersen; Gunnar Hilmar Gislason; Morten Lock Hansen
Journal:  Circulation       Date:  2012-08-06       Impact factor: 29.690

5.  Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE study.

Authors:  Lei Zhang; Yi Li; Quan-Min Jing; Xiao-Zeng Wang; Ying-Yan Ma; Geng Wang; Bo Xu; Run-Lin Gao; Ya-Ling Han
Journal:  J Interv Cardiol       Date:  2014-03-12       Impact factor: 2.279
  5 in total
  1 in total

1.  Uvula Hematoma.

Authors:  Hiroki Matsuura; Takashi Fukumura
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.